Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909.

Savransky V, Lacy M, Ionin B, Skiadopoulos MH, Shearer J.

Int J Toxicol. 2019 May/Jun;38(3):163-172. doi: 10.1177/1091581819848722.

PMID:
31179828
2.

Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.

Savransky V, Shearer JD, Gainey MR, Sanford DC, Sivko GS, Stark GV, Li N, Ionin B, Lacy MJ, Skiadopoulos MH.

Vaccine. 2017 Sep 5;35(37):4952-4959. doi: 10.1016/j.vaccine.2017.07.076. Epub 2017 Jul 31.

3.

Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Savransky V, Sanford DC, Syar E, Austin JL, Tordoff KP, Anderson MS, Stark GV, Barnewall RE, Briscoe CM, Lemiale-Biérinx L, Park S, Ionin B, Skiadopoulos MH.

Infect Immun. 2013 Apr;81(4):1152-63. doi: 10.1128/IAI.01289-12. Epub 2013 Jan 28.

4.

Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia.

Yang R, Sikka G, Larson J, Watts VL, Niu X, Ellis CL, Miller KL, Camara A, Reinke C, Savransky V, Polotsky VY, O'Donnell CP, Berkowitz DE, Barouch LA.

Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1467-76. doi: 10.1152/ajpheart.00604.2009. Epub 2011 Jan 28.

5.

Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells.

Polotsky VY, Savransky V, Bevans-Fonti S, Reinke C, Li J, Grigoryev DN, Shimoda LA.

Physiol Genomics. 2010 May;41(3):306-14. doi: 10.1152/physiolgenomics.00091.2009. Epub 2010 Mar 2.

6.

Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice.

Savransky V, Reinke C, Jun J, Bevans-Fonti S, Nanayakkara A, Li J, Myers AC, Torbenson MS, Polotsky VY.

Exp Physiol. 2009 Feb;94(2):228-39. doi: 10.1113/expphysiol.2008.044883. Epub 2008 Nov 21.

7.

Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.

Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, Steele KE, Schweizter MA, Clark JM, Torbenson MS, Schwartz AR.

Am J Respir Crit Care Med. 2009 Feb 1;179(3):228-34. doi: 10.1164/rccm.200804-608OC. Epub 2008 Oct 31. Erratum in: Am J Respir Crit Care Med. 2009 Nov 1;180(9):910-1.

8.

Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase.

Savransky V, Jun J, Li J, Nanayakkara A, Fonti S, Moser AB, Steele KE, Schweitzer MA, Patil SP, Bhanot S, Schwartz AR, Polotsky VY.

Circ Res. 2008 Nov 7;103(10):1173-80. doi: 10.1161/CIRCRESAHA.108.178533. Epub 2008 Oct 2.

9.

Intermittent hypoxia has organ-specific effects on oxidative stress.

Jun J, Savransky V, Nanayakkara A, Bevans S, Li J, Smith PL, Polotsky VY.

Am J Physiol Regul Integr Comp Physiol. 2008 Oct;295(4):R1274-81. doi: 10.1152/ajpregu.90346.2008. Epub 2008 Aug 13.

10.

Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver.

Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, Polotsky VY.

Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G871-7. Epub 2007 Aug 9.

11.

Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia.

Li J, Nanayakkara A, Jun J, Savransky V, Polotsky VY.

Physiol Genomics. 2007 Oct 22;31(2):273-80. Epub 2007 Jul 31.

PMID:
17666524
12.

Chronic intermittent hypoxia predisposes to liver injury.

Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY.

Hepatology. 2007 Apr;45(4):1007-13.

PMID:
17393512
13.

Chronic intermittent hypoxia induces atherosclerosis.

Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY.

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1290-7. Epub 2007 Mar 1.

14.

Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia.

Li J, Savransky V, Nanayakkara A, Smith PL, O'Donnell CP, Polotsky VY.

J Appl Physiol (1985). 2007 Feb;102(2):557-63. Epub 2006 Nov 2.

15.

Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury.

Ascon DB, Lopez-Briones S, Liu M, Ascon M, Savransky V, Colvin RB, Soloski MJ, Rabb H.

J Immunol. 2006 Sep 1;177(5):3380-7.

16.

Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha.

Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, Semenza GL, Polotsky VY.

Physiol Genomics. 2006 May 16;25(3):450-7. Epub 2006 Feb 28.

17.

Role of the T-cell receptor in kidney ischemia-reperfusion injury.

Savransky V, Molls RR, Burne-Taney M, Chien CC, Racusen L, Rabb H.

Kidney Int. 2006 Jan;69(2):233-8.

18.

Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury.

Molls RR, Savransky V, Liu M, Bevans S, Mehta T, Tuder RM, King LS, Rabb H.

Am J Physiol Renal Physiol. 2006 May;290(5):F1187-93. Epub 2005 Dec 20.

19.

Immunogenicity of the histidine-to-tyrosine staphylococcal enterotoxin B mutant protein in C3H/HeJ mice.

Savransky V, Pinelis D, Korolev S, Ionin B, Fegeding K.

Toxicon. 2004 Mar 15;43(4):433-8.

PMID:
15051407
20.

Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B.

Savransky V, Rostapshov V, Pinelis D, Polotsky Y, Korolev S, Komisar J, Fegeding K.

Toxicol Pathol. 2003 Jul-Aug;31(4):373-8.

PMID:
12851102
21.

Toxicity of the staphylococcal enterotoxin B mutants with histidine-to-tyrosine substitutions.

Korolev S, Pinelis D, Savransky V, Komisar J, Vogel P, Fegeding K.

Toxicology. 2003 May 3;187(2-3):229-38.

PMID:
12699911
22.

A new pair of donor-acceptor markers for immunoassay: a porphyrin-cyanine dye. Energy transfer in solutions and Langmuir films.

Chudinova GK, Nagovitsyn IA, Chudinov AV, Savransky VV, Prokhorov AM.

Dokl Biochem Biophys. 2002 Sep-Oct;386:268-70. No abstract available.

PMID:
12469506
23.

Projection system with brightness amplifier for biology and medicine.

Bunkin FV, Kazaryan MA, Kondrat'ev MA, Petrash GG, Prokhorov AM, Savransky VV, Sisakyan IN, Sitnikov GA, Zemskov KI.

Microsc Acta. 1979 Nov;82(3):229-33.

PMID:
93683

Supplemental Content

Loading ...
Support Center